384 related articles for article (PubMed ID: 31370337)
1. Metabolic Plasticity of Acute Myeloid Leukemia.
Kreitz J; Schönfeld C; Seibert M; Stolp V; Alshamleh I; Oellerich T; Steffen B; Schwalbe H; Schnütgen F; Kurrle N; Serve H
Cells; 2019 Jul; 8(8):. PubMed ID: 31370337
[TBL] [Abstract][Full Text] [Related]
2. Importance of glutamine metabolism in leukemia cells by energy production through TCA cycle and by redox homeostasis.
Goto M; Miwa H; Shikami M; Tsunekawa-Imai N; Suganuma K; Mizuno S; Takahashi M; Mizutani M; Hanamura I; Nitta M
Cancer Invest; 2014 Jul; 32(6):241-7. PubMed ID: 24762082
[TBL] [Abstract][Full Text] [Related]
3. Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling.
Corbet C; Feron O
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):7-15. PubMed ID: 28110019
[TBL] [Abstract][Full Text] [Related]
4. Very long chain fatty acid metabolism is required in acute myeloid leukemia.
Tcheng M; Roma A; Ahmed N; Smith RW; Jayanth P; Minden MD; Schimmer AD; Hess DA; Hope K; Rea KA; Akhtar TA; Bohrnsen E; D'Alessandro A; Mohsen AW; Vockley J; Spagnuolo PA
Blood; 2021 Jun; 137(25):3518-3532. PubMed ID: 33720355
[TBL] [Abstract][Full Text] [Related]
5. FBP1-Altered Carbohydrate Metabolism Reduces Leukemic Viability through Activating P53 and Modulating the Mitochondrial Quality Control System In Vitro.
Xu Y; Tran L; Tang J; Nguyen V; Sewell E; Xiao J; Hino C; Wasnik S; Francis-Boyle OL; Zhang KK; Xie L; Zhong JF; Baylink DJ; Chen CS; Reeves ME; Cao H
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232688
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Cooperation of Glucose and Glutamine Is Essential for the Lytic Cycle of Obligate Intracellular Parasite Toxoplasma gondii.
Nitzsche R; Zagoriy V; Lucius R; Gupta N
J Biol Chem; 2016 Jan; 291(1):126-41. PubMed ID: 26518878
[TBL] [Abstract][Full Text] [Related]
7. [Energy metabolism of acute myeloid leukemia cells in the bone marrow microenvironment].
Tabe Y
Rinsho Ketsueki; 2022; 63(9):1046-1051. PubMed ID: 36198528
[TBL] [Abstract][Full Text] [Related]
8. Lipids and the cancer stemness regulatory system in acute myeloid leukemia.
Lim INX; Nagree MS; Xie SZ
Essays Biochem; 2022 Sep; 66(4):333-344. PubMed ID: 35996953
[TBL] [Abstract][Full Text] [Related]
9. Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.
Rodriguez-Zabala M; Ramakrishnan R; Reinbach K; Ghosh S; Oburoglu L; Falqués-Costa A; Bellamkonda K; Ehinger M; Peña-Martínez P; Puente-Moncada N; Lilljebjörn H; Cammenga J; Pronk CJ; Lazarevic V; Fioretos T; Hagström-Andersson AK; Woods NB; Järås M
Blood Adv; 2023 Sep; 7(18):5382-5395. PubMed ID: 37505194
[TBL] [Abstract][Full Text] [Related]
10. Targeting Metabolic Dependencies Fueling the TCA Cycle to Circumvent Therapy Resistance in Acute Myeloid Leukemia.
Boët E; Sarry JE
Cancer Res; 2024 Apr; 84(7):950-952. PubMed ID: 38558131
[TBL] [Abstract][Full Text] [Related]
11. The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation.
Amaya ML; Inguva A; Pei S; Jones C; Krug A; Ye H; Minhajuddin M; Winters A; Furtek SL; Gamboni F; Stevens B; D'Alessandro A; Pollyea DA; Reigan P; Jordan CT
Blood; 2022 Jan; 139(4):584-596. PubMed ID: 34525179
[TBL] [Abstract][Full Text] [Related]
12. Glutamine Metabolism Mediates Sensitivity to Respiratory Complex II Inhibition in Acute Myeloid Leukemia.
Roma A; Tcheng M; Ahmed N; Walker S; Jayanth P; Minden MD; Hope K; Nekkar Rao PP; Luc J; Doxey AC; Reisz JA; Culp-Hill R; D'Alessandro A; Spagnuolo PA
Mol Cancer Res; 2022 Nov; 20(11):1659-1673. PubMed ID: 35994381
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
[TBL] [Abstract][Full Text] [Related]
14. Targeting Mitochondrial Oxidative Phosphorylation Eradicates Acute Myeloid Leukemic Stem Cells.
Peng M; Huang Y; Zhang L; Zhao X; Hou Y
Front Oncol; 2022; 12():899502. PubMed ID: 35574326
[TBL] [Abstract][Full Text] [Related]
15. EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax.
Fooks K; Galicia-Vazquez G; Gife V; Schcolnik-Cabrera A; Nouhi Z; Poon WWL; Luo V; Rys RN; Aloyz R; Orthwein A; Johnson NA; Hulea L; Mercier FE
J Exp Clin Cancer Res; 2022 Dec; 41(1):340. PubMed ID: 36482393
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia.
Soltani M; Ghanadian M; Ghezelbash B; Shokouhi A; Zamyatnin AA; Bazhin AV; Ganjalikhani-Hakemi M
BMC Cancer; 2023 May; 23(1):447. PubMed ID: 37193972
[TBL] [Abstract][Full Text] [Related]
17. Targeting Metabolic Reprogramming in Acute Myeloid Leukemia.
Castro I; Sampaio-Marques B; Ludovico P
Cells; 2019 Aug; 8(9):. PubMed ID: 31450562
[TBL] [Abstract][Full Text] [Related]
18. High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.
Poulain L; Sujobert P; Zylbersztejn F; Barreau S; Stuani L; Lambert M; Palama TL; Chesnais V; Birsen R; Vergez F; Farge T; Chenevier-Gobeaux C; Fraisse M; Bouillaud F; Debeissat C; Herault O; Récher C; Lacombe C; Fontenay M; Mayeux P; Maciel TT; Portais JC; Sarry JE; Tamburini J; Bouscary D; Chapuis N
Leukemia; 2017 Nov; 31(11):2326-2335. PubMed ID: 28280275
[TBL] [Abstract][Full Text] [Related]
19. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.
Simões RV; Serganova IS; Kruchevsky N; Leftin A; Shestov AA; Thaler HT; Sukenick G; Locasale JW; Blasberg RG; Koutcher JA; Ackerstaff E
Neoplasia; 2015 Aug; 17(8):671-84. PubMed ID: 26408259
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics in acute myeloid leukemia.
Wojcicki AV; Kasowski MM; Sakamoto KM; Lacayo N
Mol Genet Metab; 2020 Aug; 130(4):230-238. PubMed ID: 32457018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
